The U.S.-Japan Cooperative Medical Sciences Program (USJCMSP)
 
Mycobacteria Panel Agenda
February 9-10, 2017
Novotel Ambassador Seoul Gangnam - Champagne A, 2nd Floor
  
 
Day 1: Host Response and Pathogenesis
 
 
8:30am
Welcome & Opening Remarks
Dr. Yasuhiko Suzuki & Dr. Steven Reed
Mycobacterial Panel Chairs (Japan & USA)
 
·      Welcome from Korean hosts
Dr. Ray Cho
 
 
Session 1: Host Response
Session Chairs: Sabine Ehrt (USA), Naoto Keicho (Japan)
 
 
 
9:00am
Role of IL-17 producing γδ T cells in the granuloma formation in the lung during mycobacterial infection
Dr. Masayuki Umemura
Ryukyu University
Japan
9:20am
The Role of Neutrophils in TB Pathogenesis
Dr. Christina Stallings
Washington University
USA
9:40am
Immune Responses against Mycobacteria through C-type Lectin Receptors
Dr. Sho Yamasaki
Kyusyu University
Japan
10:00am
The fate of memory T cells during pulmonary tuberculosis
Dr. Samuel Behar
University of Massachusetts
USA
10:20am
BREAK
 
 
 
10:40am
Polymorphisms and blood expression levels of interleukin 12 receptor subunit beta 2 gene in tuberculosis
Dr. Naoto Keicho
Research Institute of Tuberculosis
Japan
11:00am
Identification of infected cell population in the lung during tuberculosis
Dr. Jinhee Lee
University of Massachusetts
USA
11:20am
Suppressive effect of mycolactone on antibody production against co-administered antigens
Dr. Noriko Shinoda
Kitasato University
Japan
11:40am
Characterization of the immune mechanisms of leprosy reactions
Dr. Kathryn Dupnik
Weill Cornell Medical College
USA
Noon
Lunch
Working Lunch for US and Japanese Panel Members: 2019 & Beyond- Planning for future meetings
·         Dr. Yasuhiko Suzuki & Dr. Steven Reed (Panel Chairs)
·         Dr. Alison Kraigsley (Mycobacterial Panel Secretariat)
1:00pm
Poster Session
 
Session 2: Pathogenesis
Session Chairs: Manabu Ato (Japan), Steven Reed (USA)
 
 
 
1:40pm
Molecular characterization of a nicotinate phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv
Dr. Shigetarou Mori
National Institute of Infectious Diseases
Japan
2:00pm
Metabolic prerequisite that enables Mycobacterium tuberculosis to co-catabolize multiple carbons within the host
Dr. Hyungjin Eoh
University of Southern California
USA
2:20pm
Epigenetic regulation of the CD82 is essential for the tuberculosis pathogenesis via RUNX1
Dr. Chul-Su Yang
Hanyang University
Republic of Korea
2:40pm
M. lepromatosis, a new organism which also causes leprosy
Dr. Richard Truman
Health Resources and Services Administration
USA
3:00pm
BREAK
 
 
 
3:20pm
Autophagy and microRNA in mycobacterial infection
Dr. Eun-Kyeong Jo
Chungnam National University School of Medicine
Republic of Korea
3:40pm
The C-type lectin DCAR is an activating receptor for mycobacterial phosphatidyl-inositol mannoside
Dr. Kenji Toyonaga
Kagoshima University
Japan
4:00pm
HDL cholesterol is the risk for Mycobacterium tuberculosis infection and suppresses TLR2-dependent TNF-α production from M. tuberculosis–infected macrophages
Dr. Sohkichi Matsumoto
Niigata University
Japan
4:20pm
Mycobacterium tuberculosis: Metabolic adaptation to host environments
Dr. Sabine Ehrt
Weill Cornell Medical College
USA
5:00pm
Poster Session
 

 
Day 2: Diagnosis, Treatment, and Prevention
 
 
8:40am
Opening Remarks
 
 
 
 
 
 
 
 
Session 3: Diagnosis
Session Chairs: Yasuhiko Suzuki (Japan), Ray Cho (Korea)
 
 
 
9:00am
Sero-diagnosis of Mycobatcerium avian complex lung diseases from international collaboration studies
Dr. Manabu Ato
National Institute of Infectious Diseases
Japan
9:20am
Production and screening of M. leprae specific antigens for detection of leprosy
Dr. Tetsu Mukai
National Institute of Infectious Diseases
Japan
9:40am
Efforts to detect paucibacillary leprosy patients by serological methods
Dr. Yumi Maeda
National Institute of Infectious Diseases
Japan
10:00am
Molecular diagnosis of tuberculosis: obstacles to be overcome
Dr. Hyeyoung Lee
College of Health Sciences,
Yonsei University
Republic of Korea
10:20am
BREAK
 
 
 
Session 4: Treatment
Session Chairs: Richard Truman (USA), Tetsu Mukai (Japan)
 
 
 
10:40am
Current status of delamanid, and a new candidate compound against Tuberculosis
Dr. Makoto Matsumoto
Otsuka Pharmaceutical Co, Ltd.
Japan
11:00am
Novel strategies to identify synergistic anti-tubercular drug targets
Dr. Yusuke Minato
University of Minnesota
USA
11:20am
Ongoing Trials for MDR-TB treatment
Dr. Jae-Joon Yim
Seoul National University College of Medicine
Republic of Korea
11:40am
Poster Session
 
 
Noon
Lunch
 
 
Session 5: Prevention
Session Chairs: Sohkichi Matsumoto (Japan), Samuel Behar (USA)
 
 
12:40pm
Innate Immune Mechanisms of Nerve Damage in Leprosy
Dr. Cressida Madigan
University of California- Los Angeles
USA
1:00pm
Optimization of prophylactic TB vaccine for adult with combinatorial adjuvants
Dr. Sang-Jun Ha
Yonsei University
Republic of Korea
1:20pm
Role of SOCS1  for establishment of  mycobacterium infection
Dr. Shogo Soma
National Institute of Biomedical Innovation, Health and Nutrition
Japan
1:40pm
Clinical Development of a Next Generation Tuberculosis Vaccine and Novel Adjuvants
 
Dr. Steven Reed
Infectious Disease Research Institute
USA
 
 
 
 
 
2:00pm
Closing Remarks
Dr. Yasuhiko Suzuki & Dr. Steven Reed
Mycobacterial Panel Chairs (Japan & USA)
 
** Note: Talks are 15 minutes + 5 minutes of discussion